1 ne disease may lead to the symptoms of scalp dysesthesia.

2 yah site in Iraq had a greater prevalence of dysesthesia.

3  is assumed to represent an index of pain or dysesthesia.

4 t is accompanied by painful paresthesias and dysesthesias.

5                                    Transient dysesthesia 1 day to 4 weeks in duration occurred in the

6 dical records as having been seen with scalp dysesthesia, 14 patients had cervical spine disease conf

7                          Patients with scalp dysesthesia also had abnormal cervical spine images.

8 rologic condition characterized by nocturnal dysesthesias and an urge to move, affecting the legs.

9 that is accompanied by painful paresthesias, dysesthesias, and occasionally hypoesthesia, and by hypo

10 pin) inhibited histamine-induced sensations, dysesthesias, and skin reactions but not the sensations

11                                      Painful dysesthesias are rarely reported for acute oxaliplatin n

12              Symptoms included paresthesias, dysesthesias, cold hypersensitivity, jaw pain, eye pain,

13 nd skin reactions but not the sensations and dysesthesias evoked by BAM8-22.

14 s with complaints of numbness, tingling, and dysesthesias in the toes and feet are frequently referre

15                                        Scalp dysesthesia is characterized by abnormal sensations of t

16 companied by one or more mechanically evoked dysesthesias, namely alloknesis, hyperknesis, and/or hyp

17 loskeletal pain, neurocognitive symptoms, or dysesthesia, often associated with fatigue.

18        The DLT was grade 3 pharyngolaryngeal dysesthesia, sensory neuropathy, and ataxia at 160 mg/m2

19             In patients presenting with hand dysesthesias, the findings that best distinguish between